Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1982 4
1983 3
1984 4
1985 3
1986 3
1987 3
1988 5
1989 6
1990 3
1991 8
1992 4
1993 7
1994 9
1995 4
1996 2
1997 13
1998 14
1999 11
2000 19
2001 15
2002 15
2003 11
2004 17
2005 16
2006 13
2007 12
2008 18
2009 13
2010 16
2011 16
2012 8
2013 11
2014 13
2015 17
2016 11
2017 13
2018 12
2019 12
2020 16
2021 19
2022 14
2023 9
2024 14
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

417 results

Results by year

Filters applied: . Clear all
Page 1
Allergic Rhinitis: A Review.
Bernstein JA, Bernstein JS, Makol R, Ward S. Bernstein JA, et al. JAMA. 2024 Mar 12;331(10):866-877. doi: 10.1001/jama.2024.0530. JAMA. 2024. PMID: 38470381 Review.
In addition, first-line treatment for mild intermittent or mild persistent allergic rhinitis may include a second-generation H1 antihistamine (eg, cetirizine, fexofenadine, desloratadine, loratadine) or an intranasal antihistamine (eg, azelastine, olopatadine), whereas pat …
In addition, first-line treatment for mild intermittent or mild persistent allergic rhinitis may include a second-generation H1 antihistamin …
Intranasal budesonide for rhinitis during a high airborne pollution period: a randomized controlled trial.
Zhang Y, Shan C, Liu W, Han Y, Shi G, Ma Y, Wagner K, Tian X, Zhang L, Larona AJ, Sacavage S, Franklin K, Wang C, Zhang L. Zhang Y, et al. Allergy Asthma Clin Immunol. 2022 Jun 20;18(1):56. doi: 10.1186/s13223-022-00686-y. Allergy Asthma Clin Immunol. 2022. PMID: 35725523 Free PMC article.
OBJECTIVE: To assess the effectiveness of intranasal budesonide in adults with self-reported rhinitis symptoms triggered/worsened by airborne pollution. ...Results for SGIC and all other individual symptoms did not show significant differences between the two groups …
OBJECTIVE: To assess the effectiveness of intranasal budesonide in adults with self-reported rhinitis symptoms triggered/worse …
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis.
Soe KK, Krikeerati T, Pheerapanyawaranun C, Niyomnaitham S, Phinyo P, Thongngarm T. Soe KK, et al. Front Pharmacol. 2023 May 23;14:1184552. doi: 10.3389/fphar.2023.1184552. eCollection 2023. Front Pharmacol. 2023. PMID: 37288109 Free PMC article. Review.
No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis (AR). ...In seasonal AR, mometasone furoate (MF) was ranked the highest efficacy, followed by fluticasone furoate (FF), ciclesonide (CIC), f …
No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis …
Intranasal administration of budesonide-loaded nanocapsule microagglomerates as an innovative strategy for asthma treatment.
Ortiz M, de Sa Coutinho D, Ciambarella BT, de Souza ET, D'Almeida APL, Durli TL, Rodrigues E Silva PM, Bernardi A, Sonvico F, Pohlmann AR, Martins MA, Guterres SS. Ortiz M, et al. Drug Deliv Transl Res. 2020 Dec;10(6):1700-1715. doi: 10.1007/s13346-020-00813-5. Drug Deliv Transl Res. 2020. PMID: 32789546
Compared with oral H(1) receptor antagonists, intranasal corticosteroids have been demonstrated to provide greater relief of all symptoms of rhinitis and are recommended as first-line treatment for allergic rhinitis. Intrinsic limitations of nasal delivery, such as the pre …
Compared with oral H(1) receptor antagonists, intranasal corticosteroids have been demonstrated to provide greater relief of all symp …
The subtle nuances of intranasal corticosteroids.
Fowler J, Rotenberg BW, Sowerby LJ. Fowler J, et al. J Otolaryngol Head Neck Surg. 2021 Mar 17;50(1):18. doi: 10.1186/s40463-020-00480-z. J Otolaryngol Head Neck Surg. 2021. PMID: 33731223 Free PMC article.
The purpose of this commentary is to review the nuances of each intranasal corticosteroid. COMMENTARY: There are nine intranasal corticosteroids approved for use in Canada. Each are discussed in detail, including their indication, bioavailability, effects on intr …
The purpose of this commentary is to review the nuances of each intranasal corticosteroid. COMMENTARY: There are nine intranasal …
A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide.
Gluck PA, Gluck JC. Gluck PA, et al. Curr Med Res Opin. 2005 Jul;21(7):1075-84. doi: 10.1185/030079905X50570. Curr Med Res Opin. 2005. PMID: 16004676 Review.
In a retrospective case-control analysis, no association was found between inhaled budesonide or intranasal budesonide and the overall rate of infant cardiovascular defects. ...Data on pregnancy outcomes after maternal exposure to intranasal budeson …
In a retrospective case-control analysis, no association was found between inhaled budesonide or intranasal budesonide …
A sensitive and high-throughput LC-ESI-MS/MS method to detect budesonide in human plasma: application to an evaluation of pharmacokinetics of budesonide intranasal formulations with and without charcoal-block in healthy volunteers.
Li X, Tong H, Xu B, Deng Y, Li Y, Huang J, Mao Y, Liu M, Zhang P, Guo S. Li X, et al. Drug Dev Ind Pharm. 2021 Feb;47(2):329-336. doi: 10.1080/03639045.2021.1879842. Epub 2021 Feb 1. Drug Dev Ind Pharm. 2021. PMID: 33523774
Budesonide is one of the intranasal corticosteroids, referred as first-line therapy for allergic rhinitis. ...Moreover, the newly developed method was successfully applied to the evaluation of pharmacokinetics of two budesonide intranasal formulations …
Budesonide is one of the intranasal corticosteroids, referred as first-line therapy for allergic rhinitis. ...Moreover, the ne …
Intranasal Budesonide and Quality of Life in Pediatric Sleep-Disordered Breathing: A Randomized Controlled Trial.
Gudnadottir G, Ellegård E, Hellgren J. Gudnadottir G, et al. Otolaryngol Head Neck Surg. 2018 Apr;158(4):752-759. doi: 10.1177/0194599817742597. Epub 2017 Nov 21. Otolaryngol Head Neck Surg. 2018. PMID: 29161199 Clinical Trial.
An intention-to-treat analysis revealed a significantly greater improvement in the mean OSA-18 total score after treatment with budesonide than placebo (19.5 vs 7.5, P = .0014). Intranasal budesonide also improved 2 OSA-18 domains (sleep disturbance, caregive …
An intention-to-treat analysis revealed a significantly greater improvement in the mean OSA-18 total score after treatment with budesonid …
Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L, Zhu YH, Liu DX, Li J, Zhao PC, Zhong YP, Chen YQ, Xu W, Zhu ZQ. Dong L, et al. J Immunol Res. 2019 Feb 27;2019:7264383. doi: 10.1155/2019/7264383. eCollection 2019. J Immunol Res. 2019. PMID: 30937316 Free PMC article.
METHODS: Adult male C57BL/6 mice were divided into three groups: control, ALI, and ALI + budesonide groups. LPS (5 mg/kg) was intratracheally injected to induce ALI in mice. Budesonide (0.5 mg/kg) was intranasally given 1 h before LPS administration in the AL …
METHODS: Adult male C57BL/6 mice were divided into three groups: control, ALI, and ALI + budesonide groups. LPS (5 mg/kg) was intratr …
417 results